These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 24338092

  • 1. Heterogeneous glycopeptide intermediate Staphylococcus epidermidis isolated from prosthetic joint infections.
    Tevell S, Claesson C, Hellmark B, Söderquist B, Nilsdotter-Augustinsson Å.
    Eur J Clin Microbiol Infect Dis; 2014 Jun; 33(6):911-7. PubMed ID: 24338092
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Prevalence of isolates with reduced glycopeptide susceptibility in orthopedic device-related infections due to methicillin-resistant Staphylococcus aureus.
    Vaudaux P, Ferry T, Uçkay I, François P, Schrenzel J, Harbarth S, Renzoni A.
    Eur J Clin Microbiol Infect Dis; 2012 Dec; 31(12):3367-74. PubMed ID: 22833247
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Investigation of reduced susceptibility to glycopeptides among methicillin-resistant Staphylococcus aureus isolates from patients in Ireland and evaluation of agar screening methods for detection of heterogeneously glycopeptide-intermediate S. aureus.
    Fitzgibbon MM, Rossney AS, O'Connell B.
    J Clin Microbiol; 2007 Oct; 45(10):3263-9. PubMed ID: 17687008
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of a new Etest vancomycin-teicoplanin strip for detection of glycopeptide-intermediate Staphylococcus aureus (GISA), in particular, heterogeneous GISA.
    Yusof A, Engelhardt A, Karlsson A, Bylund L, Vidh P, Mills K, Wootton M, Walsh TR.
    J Clin Microbiol; 2008 Sep; 46(9):3042-7. PubMed ID: 18596146
    [Abstract] [Full Text] [Related]

  • 7. In vitro activity of tedizolid and linezolid against Staphylococcus epidermidis isolated from prosthetic joint infections.
    Littorin C, Hellmark B, Nilsdotter-Augustinsson Å, Söderquist B.
    Eur J Clin Microbiol Infect Dis; 2017 Sep; 36(9):1549-1552. PubMed ID: 28326447
    [Abstract] [Full Text] [Related]

  • 8. Antibiotic susceptibility among Staphylococcus epidermidis isolated from prosthetic joint infections with special focus on rifampicin and variability of the rpoB gene.
    Hellmark B, Unemo M, Nilsdotter-Augustinsson A, Söderquist B.
    Clin Microbiol Infect; 2009 Mar; 15(3):238-44. PubMed ID: 19196261
    [Abstract] [Full Text] [Related]

  • 9. Comparison of teicoplanin and vancomycin in vitro activity on clinical isolates of Staphylococcus aureus.
    Tascini C, Flammini S, Leonildi A, Ciullo I, Tagliaferri E, Menichetti F.
    J Chemother; 2012 Aug; 24(4):187-90. PubMed ID: 23040680
    [Abstract] [Full Text] [Related]

  • 10. Presence of multiple van genes among glycopeptide non-susceptible Staphylococcus aureus exhibiting in vitro MIC creep phenomenon: A study from north-east India.
    Hazarika M, Nath K, Bhowmik D, Singha KM, Dhar D, Bhattacharjee A.
    Indian J Med Res; 2024 Jul; 160(1):109-117. PubMed ID: 39382498
    [Abstract] [Full Text] [Related]

  • 11. Characterization of Teicoplanin Nonsusceptible Staphylococcus epidermidis Clinical Isolates Belonging Predominantly to ST267.
    Liu C, Zhang F, Chen C, Feng X, Xu M, Guo X, Sun J, Li G, Zhu P, Zeng L, Xu H, Wang H, Li X, Ming L.
    Microb Drug Resist; 2017 Apr; 23(3):321-327. PubMed ID: 27314582
    [Abstract] [Full Text] [Related]

  • 12. Investigation of Staphylococcus strains with heterogeneous resistance to glycopeptides in a Turkish university hospital.
    Nakipoglu Y, Derbentli S, Cagatay AA, Katranci H.
    BMC Infect Dis; 2005 May 05; 5():31. PubMed ID: 15871748
    [Abstract] [Full Text] [Related]

  • 13. A 1 year surveillance study of glycopeptide-intermediate Staphylococcus aureus strains in a French hospital.
    Garnier F, Chainier D, Walsh T, Karlsson A, Bolmström A, Grelaud C, Mounier M, Denis F, Ploy MC.
    J Antimicrob Chemother; 2006 Jan 05; 57(1):146-9. PubMed ID: 16286482
    [Abstract] [Full Text] [Related]

  • 14. Draft genome sequences of three clinical isolates of teicoplanin-resistant Staphylococcus epidermidis from patients without prior exposure to glycopeptide antibiotics.
    Vimberg V, Zieglerova L, Závora J, Šemberová L, Prásilová J, Adámková V, Novotna GB.
    J Glob Antimicrob Resist; 2019 Mar 05; 16():251-253. PubMed ID: 30797086
    [Abstract] [Full Text] [Related]

  • 15. In-vitro characteristics of glycopeptide resistant strains of Staphylococcus epidermidis isolated from patients on CAPD.
    Sanyal D, Johnson AP, George RC, Edwards R, Greenwood D.
    J Antimicrob Chemother; 1993 Aug 05; 32(2):267-78. PubMed ID: 8226428
    [Abstract] [Full Text] [Related]

  • 16. Staphylococcus aureus with reduced glycopeptide susceptibility in Liverpool, UK.
    Kirby A, Graham R, Williams NJ, Wootton M, Broughton CM, Alanazi M, Anson J, Neal TJ, Parry CM.
    J Antimicrob Chemother; 2010 Apr 05; 65(4):721-4. PubMed ID: 20124288
    [Abstract] [Full Text] [Related]

  • 17. Detection of Staphylococcus aureus isolates with heterogeneous intermediate-level resistance to vancomycin in the United States.
    Richter SS, Satola SW, Crispell EK, Heilmann KP, Dohrn CL, Riahi F, Costello AJ, Diekema DJ, Doern GV.
    J Clin Microbiol; 2011 Dec 05; 49(12):4203-7. PubMed ID: 21976769
    [Abstract] [Full Text] [Related]

  • 18. Decreased susceptibility to teicoplanin and vancomycin in coagulase-negative Staphylococci isolated from orthopedic-device-associated infections.
    Cremniter J, Slassi A, Quincampoix JC, Sivadon-Tardy V, Bauer T, Porcher R, Lortat-Jacob A, Piriou P, Judet T, Herrmann JL, Gaillard JL, Rottman M.
    J Clin Microbiol; 2010 Apr 05; 48(4):1428-31. PubMed ID: 20164270
    [Abstract] [Full Text] [Related]

  • 19. Glycopeptide resistance in coagulase-negative staphylococci.
    Biavasco F, Vignaroli C, Varaldo PE.
    Eur J Clin Microbiol Infect Dis; 2000 Jun 05; 19(6):403-17. PubMed ID: 10947214
    [Abstract] [Full Text] [Related]

  • 20. Underestimation of vancomycin and teicoplanin MICs by broth microdilution leads to underdetection of glycopeptide-intermediate isolates of Staphylococcus aureus.
    Vaudaux P, Huggler E, Bernard L, Ferry T, Renzoni A, Lew DP.
    Antimicrob Agents Chemother; 2010 Sep 05; 54(9):3861-70. PubMed ID: 20547791
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.